PTHLH and breast cancer: Plasma PTHrP concentrations are greater in patients with breast cancer bone metastases and hypercalcemia when compared to early breast cancer patients and those with bone metastases and normal serum calcium concentrations, suggesting both a paracrine and endocrine role for PTHrP in breast cancer-associated hypercalcemia [14].